Devx Energy Inc (DVXE) Stock Price

28.1661 ▲ +0.9306 (+3.42%)
Open: 28.1661 Vol: 2 Day's range: 28.1661 - 28.1661 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DVXE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 25.59▲ 25.69▼ 25.82▼ 27.52▲ 26.48▲
MA10 25.60▼ N/A     N/A     26.80▲ 26.59▲
MA20 N/A     N/A     N/A     26.39▲ N/A    
MA50 N/A     N/A     N/A     26.54▲ N/A    
MA100 N/A     N/A     N/A     N/A     N/A    
MA200 N/A     N/A     N/A     N/A     N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD N/A     N/A     N/A     0.228▲ N/A    
RSI 66.051▲ N/A     N/A     64.193▲ 61.975▲
STOCH N/A     N/A     N/A     88.681▲ N/A    
WILL %R -88.095▼ N/A     N/A     0.000▲ -9.913▲
CCI -44.346     N/A     N/A     150.780▲ 130.625▲
Latest Filters Detected On DVXE
▲ GAP $DVXE Open Gap Up %3 Set Alert
▲ GAP $DVXE Open Gap Up %2 Set Alert
▲ BREAK $DVXE Price Breaks 30 Days High Set Alert
▲ BREAK $DVXE Price Breaks 20 Days High Set Alert
▲ BREAK $DVXE Price Breaks 10 Days High Set Alert
CDL $DVXE Doji Candlestick Pattern Detected Set Alert
Devx Energy Inc News
Dynavax targets 60% U.S. hepatitis B market share by 2030 amid new COVID-19 vaccine deal and expanded share repurchase
Wednesday, November 05, 2025 07:31 PM
Casale projected that HEPLISAV-B could reach at least 60% total market share in the U.S. by 2030, supported by expanding retail adoption and ongoing institutional demand.
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Wednesday, November 05, 2025 01:12 PM
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a ...
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Wednesday, November 05, 2025 01:10 PM
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...
DVXE historical stock data
date open high low close volume
14/11/25 28.1661 28.1661 28.1661 28.1661 2
13/11/25 27.2355 27.2355 27.2355 27.2355 2
12/11/25 27.0974 27.0974 27.0974 27.0974 6
11/11/25 27.93 27.93 27.8781 27.8781 178
10/11/25 26.98 27.20 26.98 27.20 100
07/11/25 26.7911 26.7911 26.7911 26.7911 2
06/11/25 26.1768 26.1768 26.1768 26.1768 10
05/11/25 25.7517 25.7517 25.7517 25.7517 110
04/11/25 25.605 25.605 25.605 25.605 110
03/11/25 26.137 26.137 26.137 26.137 100
Quote Details
52wk Low:24.232
52wk High:28.599
Vol:2
Avg Vol(3m):687.7
1Y Chng:+0.00%
1M Chng:+3.37%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00